NO980466D0 - Anvendelse av sulfaminsyrederivater, acyl-sulfonamider eller sulfonylkarbamater for fremstilling av et medikament for å redusere lipoproteinnivåer - Google Patents

Anvendelse av sulfaminsyrederivater, acyl-sulfonamider eller sulfonylkarbamater for fremstilling av et medikament for å redusere lipoproteinnivåer

Info

Publication number
NO980466D0
NO980466D0 NO980466A NO980466A NO980466D0 NO 980466 D0 NO980466 D0 NO 980466D0 NO 980466 A NO980466 A NO 980466A NO 980466 A NO980466 A NO 980466A NO 980466 D0 NO980466 D0 NO 980466D0
Authority
NO
Norway
Prior art keywords
pct
sulfonylcarbamates
acylsulfonamides
medicament
manufacture
Prior art date
Application number
NO980466A
Other languages
English (en)
Norwegian (no)
Other versions
NO980466L (no
Inventor
Brian Robert Krause
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO980466D0 publication Critical patent/NO980466D0/no
Publication of NO980466L publication Critical patent/NO980466L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO980466A 1995-08-04 1998-02-03 Anvendelse av sulfaminsyrederivater, acyl-sulfonamider eller sulfonylkarbamater for fremstilling av et medikament for å redusere lipoproteinnivåer NO980466L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04
PCT/US1996/011366 WO1997005868A1 (fr) 1995-08-04 1996-07-08 Utilisation de derives d'acide sulfamique, d'acyl sulfonamides ou de sulfonyl carbamates pour la fabrication d'un medicament permettant d'abaisser les taux de lipoproteines

Publications (2)

Publication Number Publication Date
NO980466D0 true NO980466D0 (no) 1998-02-03
NO980466L NO980466L (no) 1998-02-03

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980466A NO980466L (no) 1995-08-04 1998-02-03 Anvendelse av sulfaminsyrederivater, acyl-sulfonamider eller sulfonylkarbamater for fremstilling av et medikament for å redusere lipoproteinnivåer

Country Status (27)

Country Link
US (1) US6117909A (fr)
EP (1) EP0841913B1 (fr)
JP (1) JPH11510184A (fr)
KR (1) KR19990036127A (fr)
CN (1) CN1192140A (fr)
AT (1) ATE232097T1 (fr)
AU (1) AU716255B2 (fr)
BG (1) BG63863B1 (fr)
CA (1) CA2221729A1 (fr)
CZ (1) CZ26198A3 (fr)
DE (1) DE69626118T2 (fr)
DK (1) DK0841913T3 (fr)
EA (1) EA002435B1 (fr)
EE (1) EE9800037A (fr)
ES (1) ES2191762T3 (fr)
GE (1) GEP20012511B (fr)
HR (1) HRP960341A2 (fr)
HU (1) HUP9900668A3 (fr)
IL (1) IL122247A0 (fr)
NO (1) NO980466L (fr)
NZ (1) NZ312571A (fr)
PL (1) PL185943B1 (fr)
PT (1) PT841913E (fr)
SK (1) SK12598A3 (fr)
UA (1) UA46030C2 (fr)
WO (1) WO1997005868A1 (fr)
ZA (1) ZA966617B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (fr) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Utilisation d'inhibiteurs de l'acétylcoenzime A pour traiter l'Alzheimer
EA200100153A1 (ru) * 1998-07-21 2001-08-27 Варнер-Ламберт Компани Совместное назначение ингибиторов асат и ммр для лечения атеросклеротических поражений
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
JP2003513909A (ja) * 1999-11-05 2003-04-15 ワーナー−ランバート・カンパニー Ａｃａｔ阻害剤によるプラーク破裂の予防
CA2369967A1 (fr) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methodes de traitement de maladies et de troubles relies au facteur nucleaire-kappa b
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
AR113878A1 (es) 2017-11-14 2020-06-24 Merck Sharp & Dohme Compuestos de biarilo sustituido como inhibidores de indolamina 2,3-dioxigenasa (ido)
WO2019099294A1 (fr) 2017-11-14 2019-05-23 Merck Sharp & Dohme Corp. Nouveaux composés biaryles substitués utilisés en tant qu'inhibiteurs de l'indoléamine 2,3-dioxygénase (ido)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
WO1992007826A1 (fr) * 1990-10-30 1992-05-14 Warner-Lambert Company Carbamates d'oxysulfonyle
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

Also Published As

Publication number Publication date
AU716255B2 (en) 2000-02-24
JPH11510184A (ja) 1999-09-07
GEP20012511B (en) 2001-08-27
AU6454196A (en) 1997-03-05
PL185943B1 (pl) 2003-09-30
US6117909A (en) 2000-09-12
EE9800037A (et) 1998-08-17
HRP960341A2 (en) 1998-02-28
PL324908A1 (en) 1998-06-22
EP0841913B1 (fr) 2003-02-05
HUP9900668A3 (en) 2000-08-28
BG63863B1 (bg) 2003-04-30
ATE232097T1 (de) 2003-02-15
EA002435B1 (ru) 2002-04-25
ES2191762T3 (es) 2003-09-16
CZ26198A3 (cs) 1998-07-15
HUP9900668A2 (hu) 1999-06-28
EA199800176A1 (ru) 1998-10-29
DE69626118D1 (de) 2003-03-13
CA2221729A1 (fr) 1997-02-20
DE69626118T2 (de) 2003-11-27
DK0841913T3 (da) 2003-05-05
EP0841913A1 (fr) 1998-05-20
KR19990036127A (ko) 1999-05-25
CN1192140A (zh) 1998-09-02
IL122247A0 (en) 1998-04-05
NZ312571A (en) 2000-07-28
SK12598A3 (en) 1999-02-11
UA46030C2 (uk) 2002-05-15
ZA966617B (en) 1997-02-18
BG102222A (en) 1998-09-30
PT841913E (pt) 2003-06-30
WO1997005868A1 (fr) 1997-02-20
NO980466L (no) 1998-02-03

Similar Documents

Publication Publication Date Title
ES2102195T3 (es) Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides.
DE69430816D1 (de) Verwendung von Piperidin-Derivaten in der Behandlung von Schizophrenie
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO980466D0 (no) Anvendelse av sulfaminsyrederivater, acyl-sulfonamider eller sulfonylkarbamater for fremstilling av et medikament for å redusere lipoproteinnivåer
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
FI970279A (fi) Orgaanisia yhdisteitä
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
FI933492A (fi) Lipoxigenas inhiberande hydroxaminsyra- och n-hydroxiureaderivat
DE69616357D1 (de) Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
MX9709275A (es) Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
DE69816832D1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
DE69626301D1 (de) Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen
DE69227899D1 (de) Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen
SE9401965D0 (sv) New compounds
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
ATE7298T1 (de) Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application